摘要
阿尔茨海默氏病(AD)是目前最常见的一种无法治愈的痴呆症。由于目前的人口变化,受这种疾病影响的人数预计将在未来几十年内迅速增长。由于阿尔茨海默氏病的药物治疗是相当昂贵的,研究人员试图寻找患阿尔茨海默氏病的一个这样的非药物治疗方法。替代治疗方法之一是营养干预。这个过程的目的是探讨问题多营养干预管理阿尔茨海默氏病,特别集中在医疗食品和地中海饮食。该方法包括文献综述的方法,可用的来源,和比较不同的研究研究分析这个主题。这篇评论研究的结果表明,多营养干预似乎带来了许多好处,如患者的认知下降延迟,非侵入性的延迟和成本较低的治疗或无或少的副作用。此外,为了最大限度地减少阿尔茨海默氏病的风险,一个多因素健康的生活方式的方法应该由中年人来实施。
关键词: 阿尔茨海默病,干预,管理,医疗食品,地中海饮食,营养
Current Alzheimer Research
Title:Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer’s Disease – A Mini-Review
Volume: 13 Issue: 12
Author(s): Blanka Klimova, Kamil Kuca
Affiliation:
关键词: 阿尔茨海默病,干预,管理,医疗食品,地中海饮食,营养
摘要: Alzheimer’s disease (AD) is currently the most common incurable forms of dementia. The number of people affected by this disease is expected to grow rapidly in the next decades due to the present demographic changes. Since the pharmacological treatment of AD is quite costly, researchers try to look for alternative treatments for patients suffering from AD. One of such nonpharmacological approaches is nutritional intervention. The purpose of this minireview is to explore the issue of multi-nutrient intervention in the management of AD with special focus on medical foods and Mediterranean diet. The methods include a method of literature review of available sources, and a method of comparison of different research studies analyzing this topic. The findings of this review study indicate that multi-nutrient intervention seem to bring many benefits for AD patients such as the delay of cognitive decline, non-invasive and less costly treatment or none or fewer side effects. In addition, to minimize the risk of AD, a multi-factorial healthy lifestyle approach should be implemented by people already at their mid-life.
Export Options
About this article
Cite this article as:
Blanka Klimova, Kamil Kuca , Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer’s Disease – A Mini-Review, Current Alzheimer Research 2016; 13 (12) . https://dx.doi.org/10.2174/1567205013666160603000623
DOI https://dx.doi.org/10.2174/1567205013666160603000623 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch
Anti-Cancer Agents in Medicinal Chemistry Drug Delivery Systems with Modified Release for Systemic and Biophase Bioavailability
Current Clinical Pharmacology Clinical, Genetic, and Neuroimaging Features of Early Onset Alzheimer Disease: The Challenges of Diagnosis and Treatment
Current Alzheimer Research Medicinal Plants for the Prevention and Treatment of Bacterial Infections
Current Pharmaceutical Design Targeting Epithelial-Mesenchymal Transition Phenotype for Gastro-Intestinal Cancer
Current Pharmaceutical Design A New Approach Against Some Oral Pathogenic Bacteria Using a Chimeric Antimicrobial Peptide Derived from the Camel Milk; Lactoferrampin - Lactoferricin Chimer
Current Drug Discovery Technologies Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier
Current Drug Metabolism Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science The Role of Apoptosis in Influenza Virus Pathogenesis and the Mechanisms Involved in Anti-Influenza Therapies
Current Chemical Biology Zebrafish Model in Drug Safety Assessment
Current Pharmaceutical Design Epidemiology of Candida albicans Infections and Role of Non-Candidaalbicans Yeasts
Current Drug Targets The Two Faces of Iminoalditols: Powerful Inhibitors Trigger Glycosidase Activation
Current Enzyme Inhibition NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment
Current Medicinal Chemistry Targeting MDM2 and MDMX in Retinoblastoma
Current Cancer Drug Targets Gender as a Regulator of Atherosclerosis in Murine Models
Current Drug Targets Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Current Topics in Medicinal Chemistry Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-kappa (PTPκ) and Protein Tyrosine Phosphatase-mu (PTPμ)
Current Signal Transduction Therapy Quantitative Color Doppler Ultrasonography Measurement of Thyroid Blood Flow in Patients with Graves’ Disease
Current Medical Imaging In vivo Evaluation and Alzheimer’s Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System
Current Pharmaceutical Biotechnology A Possible Approach for Stem Cell Gene Therapy of Fanconi Anemia
Current Gene Therapy